T1	Participants 53 98	nonmelanoma skin cancer in a randomized trial
T2	Participants 326 406	1312 patients from the Eastern United States who had previously had this disease
T3	Participants 408 466	Results from September 15, 1983, through December 31, 1993
T4	Participants 637 668	which ended on January 31, 1996
